ASTA Comments to FDA on Sesame Allergens
ASTA issued comments to the Food and Drug Administration (FDA) in December 2018 in response to the FDA's Request for Comment on Sesame as an Allergen in Foods. The comments support labeling sesame as a major allergen, provided that sufficient time is offered to implement new labeling and GMP requirements.
12/31/2018 at 5:15 am
0
Related Resources
NCFIA Comments Regarding FDA/CBP Coordination on Prior Notice Requirements
NCFIA issued comments to the Food and Drug Administration in May 2004 regarding joint FDA and Customs and Border Protection plans for increasing integration and assessing the coordination of prior notice timeframes.
ASTA Comments on FDA's Post-Market Assessment of Chemicals in Food
In January 2025, ASTA submitted comments to the U.S. Food and Drug Administration (FDA) on its discussion paper on the development of an enhanced systematic process for the post-market assessment of chemicals in food. ASTA's comment note that environmental contaminants are unique and should be addressed using a separate or modified approach to that used for intentionally added chemicals. The comments also call for the development of additional guidance to assist industry with setting appropriate thresholds for contaminants.
